Lyme Disease Is Spiking. This Biotech Nears A Treatment And A Buy Point.

Published 2 months ago Positive
Lyme Disease Is Spiking. This Biotech Nears A Treatment And A Buy Point.
Auto
This biotech is nearing a buy point of a cup base. The company has a treatment for Lyme disease in its pipeline.

Continue Reading

View Comments

More News

Þuríður Björg Guðnadóttir Appointed CEO of Ljósleiðarinn

21 hours ago Positive

Saudi Arabia Plastic Recycling Market Analysis Report 2025-2034: Increasing Demand for Polyethylene Terephthalate (PET) to Aid Growth

21 hours ago Positive

Uxin joins hand with Yinchuan authorities for used car superstore

21 hours ago Positive

Saudi Arabia Pet Care Analysis, Forecast Trends and Outlook Report 2025-2034: Market to Grow at a CAGR of 7.2%, Fueled by Growing Birds Segment and Increasing Affordability of Pet Care Products

22 hours ago Positive

Intelligent Network Market Set to Reach USD 42.2 Billion by 2032, Growing at a CAGR of 27.49% | Research by SNS Insider

22 hours ago Positive